{"id":"https://openalex.org/W4408555330","doi":"https://doi.org/10.1055/s-0045-1804568","title":"Klinisch relevante Verbesserungen mit der einmal t\u00e4glichen Dreifachfixkombination Fluticasonfuroat/Umeclidinium/Vilanterol bei der Therapie der symptomatischen COPD: Post-hoc-Subgruppenanalyse der ELLITHE-Studie","display_name":"Klinisch relevante Verbesserungen mit der einmal t\u00e4glichen Dreifachfixkombination Fluticasonfuroat/Umeclidinium/Vilanterol bei der Therapie der symptomatischen COPD: Post-hoc-Subgruppenanalyse der ELLITHE-Studie","publication_year":2025,"publication_date":"2025-03-01","ids":{"openalex":"https://openalex.org/W4408555330","doi":"https://doi.org/10.1055/s-0045-1804568"},"language":"de","primary_location":{"id":"doi:10.1055/s-0045-1804568","doi":"https://doi.org/10.1055/s-0045-1804568","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0045-1804568","pdf_url":null,"source":{"id":"https://openalex.org/S111957458","display_name":"Pneumologie","issn_l":"0934-8387","issn":["0934-8387","1438-8790"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumologie","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110461523","display_name":"K.M. Beeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115328","display_name":"Respiratory Research Institute","ror":"https://ror.org/029rf8d44","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210115328"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Beeh","raw_affiliation_strings":["Insaf Institut F\u00fcr Atemwegsforschung GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Insaf Institut F\u00fcr Atemwegsforschung GmbH","institution_ids":["https://openalex.org/I4210115328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020159629","display_name":"Karl Scheithe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267067","display_name":"GKM Gesellschaft f\u00fcr Therapieforschung mbH (Germany)","ror":"https://ror.org/012peaf20","country_code":"DE","type":"company","lineage":["https://openalex.org/I4405267067"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Scheithe","raw_affiliation_strings":["Gkm Gesellschaft f\u00fcr Therapieforschung Mbh; N/A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gkm Gesellschaft f\u00fcr Therapieforschung Mbh; N/A","institution_ids":["https://openalex.org/I4405267067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108540806","display_name":"H Schmutzler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268658","display_name":"Berlin-Chemie AG (Germany)","ror":"https://ror.org/01n4sqg38","country_code":"DE","type":"company","lineage":["https://openalex.org/I4405268658"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H Schmutzler","raw_affiliation_strings":["Berlin Chemie Ag; N/A; Medizin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berlin Chemie Ag; N/A; Medizin","institution_ids":["https://openalex.org/I4405268658"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004232261","display_name":"S Kr\u00fcger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268658","display_name":"Berlin-Chemie AG (Germany)","ror":"https://ror.org/01n4sqg38","country_code":"DE","type":"company","lineage":["https://openalex.org/I4405268658"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S Kr\u00fcger","raw_affiliation_strings":["Berlin Chemie Ag; Abteilung Medizin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berlin Chemie Ag; Abteilung Medizin","institution_ids":["https://openalex.org/I4405268658"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/umeclidinium","display_name":"umeclidinium","score":0.9879999756813049},{"id":"https://openalex.org/keywords/vilanterol","display_name":"vilanterol","score":1.0},{"id":"https://openalex.org/keywords/triple-fixed-dose-combination","display_name":"triple fixed-dose combination","score":0.7300000190734863},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.6679999828338623},{"id":"https://openalex.org/keywords/responder-analysis","display_name":"responder analysis","score":0.7860000133514404},{"id":"https://openalex.org/keywords/copd-assessment-test","display_name":"COPD Assessment Test","score":0.7900000214576721},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.9269999861717224},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.9419999718666077},{"id":"https://openalex.org/keywords/super-responders","display_name":"super-responders","score":0.6510000228881836},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5619999766349792},{"id":"https://openalex.org/keywords/laba-ics","display_name":"LABA/ICS","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8599594831466675},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4329233765602112}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-0045-1804568","doi":"https://doi.org/10.1055/s-0045-1804568","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0045-1804568","pdf_url":null,"source":{"id":"https://openalex.org/S111957458","display_name":"Pneumologie","issn_l":"0934-8387","issn":["0934-8387","1438-8790"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumologie","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392648811","https://openalex.org/W4404097311","https://openalex.org/W4412371960","https://openalex.org/W4390929490","https://openalex.org/W2618638483","https://openalex.org/W4327934536","https://openalex.org/W2883793095","https://openalex.org/W4412638771","https://openalex.org/W3092733351","https://openalex.org/W6939567863"],"abstract_inverted_index":{"Hintergrund":[0],":":[1,75,120,202],"ELLITHE":[2],"war":[3],"eine":[4,82],"nichtinterventionelle":[5],"Studie,":[6],"die":[7,8,81,127,196,228],"einmal":[9],"t\u00e4gliche":[10],"Dreifachfixkombination":[11],"mit":[12,28,58,163,190],"dem":[13,17,22],"ICS":[14],"Fluticasonfuroat":[15],"(FF),":[16],"LAMA":[18],"Umeclidinium":[19],"(UMEC)":[20],"und":[21,40,55,111,137,149,183,218],"LABA":[23],"Vilanterol":[24],"(VI)":[25],"in":[26,168],"Patienten":[27,124,134,143,189,198],"chronisch":[29],"obstruktiver":[30],"Lungenerkrankung":[31],"(COPD)":[32],"untersuchte.":[33],"In":[34,76],"der":[35,50,77,133,142,157,197,199,220],"Gesamtpopulation":[36],"wurden":[37,90],"schnelle,":[38],"nachhaltige":[39],"statistisch":[41],"signifikante":[42],"Verbesserungen":[43,95,167],"im":[44,214],"COPD":[45],"Assessment":[46],"Test":[47],"(CAT),":[48],"bei":[49,219],"Einsekundenkapazit\u00e4t":[51],"(FEV":[52],"1":[53,106,147,181,217],")":[54],"weiteren":[56],"Endpunkten":[57],"FF/UMEC/VI":[59,211],"gezeigt.":[60],"Der":[61],"individuelle":[62],"klinische":[63],"Nutzen":[64],"kann":[65],"jedoch":[66],"variieren,":[67],"hier":[68],"k\u00f6nnen":[69],"Responder-Analysen":[70,91,128],"wertvolle":[71],"Zusatzinformationen":[72],"liefern.":[73],"Methode":[74],"Population":[78],"aller":[79],"Patienten,":[80],"Vortherapie":[83,223],"aus":[84],"LAMA/LABA,":[85],"LABA/ICS":[86,191],"oder":[87,102],"ICS/LAMA/LABA":[88],"hatten,":[89],"f\u00fcr":[92,126,179,188],"klinisch":[93,165,212],"relevante":[94],"des":[96,230],"CAT":[97],"(minimal:\u2265-2":[98],"Punkte;":[99],"stark:\u2265-4":[100],"Punkte":[101],"Gesamtscore<10":[103],"Punkte),":[104],"FEV":[105,146,180,216],"(minimal:\u2265+100":[107],"mL;":[108],"stark:\u2265+200":[109],"mL)":[110],"Exazerbationen":[112,184],"(kein":[113],"Ereignis)":[114],"nach":[115,208],"12":[116],"Monaten":[117],"durchgef\u00fchrt.":[118],"Ergebnisse":[119],"Daten":[121],"von":[122],"617":[123],"waren":[125,131,144,154,161,194],"verf\u00fcgbar.":[129],"Insgesamt":[130],"53,3%":[132],"minimale":[135,145],"CAT-Responder":[136],"41,5%":[138],"starke":[139,151],"Responder.":[140,152],"36,7%":[141],"-Responder":[148],"23,5%":[150],"90,2%":[153],"exazerbationsfrei":[155],"innerhalb":[156],"12-monatigen":[158],"Beobachtungsdauer.":[159],"21,0%":[160],"\u201cSuper-Responder\u201d":[162],"minimalen":[164],"relevanten":[166],"allen":[169],"drei":[170],"Endpunkten.":[171],"Die":[172,222],"Responderraten":[173],"unterschieden":[174],"sich":[175,207],"zwischen":[176],"den":[177],"Vortherapiegruppen":[178],"(p<0,05)":[182],"(p<0,01),":[185],"wobei":[186],"sie":[187],"jeweils":[192],"h\u00f6her":[193],"als":[195],"Vergleichsgruppen.":[200],"Schlussfolgerung":[201],"COPD-Patienten":[203],"dieser":[204],"ELLITHE-Subgruppenanalyse":[205],"verbesserten":[206],"Umstellung":[209],"auf":[210,227],"relevant":[213],"CAT,":[215],"Exazerbationssenkung.":[221],"hatte":[224],"einen":[225],"Einfluss":[226],"St\u00e4rke":[229],"Effekts.":[231],"Publication":[232],"History":[233],"Article":[234],"published":[235],"online:":[236],"18":[237],"March":[238],"2025":[239],"\u00a9":[240],"2025.":[241],"Thieme.":[242],"All":[243],"rights":[244],"reserved.":[245],"Georg":[246],"Thieme":[247],"Verlag":[248],"KG":[249],"Oswald-Hesse-Stra\u00dfe":[250],"50,":[251],"70469":[252],"Stuttgart,":[253],"Germany":[254]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-03-19T00:00:00"}